Needle Biopsy Market Development Status, and Comprehensive Research Study

Global Needle Biopsy Market is valued approximately USD 552.80 million in 2019 and is anticipated to grow with a healthy growth rate of more than 5.20 % over the forecast period 2020-2027. Needle biopsy is a process which is used to collect the sampled of cells from the body. The fine needle biopsy and core needle biopsy are two types of common needle biopsy. They are usually used to take samples from the muscle, bones and other part of the body. Also, the needle biopsy is usually done to detect certain symptoms such as infection, inflammation and mass or lump. In addition, this is considered as a key approach to rule out or diagnose breast cancer. Core needle biopsy is done for the lump or palpable mass that can be felt, or suspicious area which is seen after imaging test or mammogram.

Also, the key players are focusing on strategies such as product launch, innovation and merger & acquisition to sustain themselves amidst fierce competition. Increasing prevalence of breast cancer along with the technological advancement and development in cancer related studies would drive the growth of the market during the forecast period of 2020-2027. As per the Our World in Data Organization, breast cancer is the most prevalent form of cancer with an estimated number of about 17 million people with has breast cancer in 2017. Further, as per the source, in 2018, about 2 million new cases were registered breast cancer worldwide. As per the American cancer society, breast cancer is the second leading cause of cancer-related deaths in women across the globe.

Click Here to Download Sample Report >>

Further, as per the aforementioned source, one in eight women in the United States develops invasive breast cancer over the course of her lifetime. Similarly, as per the Canadian cancer society organization 2017, in Canada on an average, about 72 women were diagnosed with the breast cancer every day, whereas 14 women died with cancer every day. Thus, the need & utility for the needle biopsy would increase thereby, aiding the growth of the market. However, high price of the needle biopsy is hampering the growth of the market during the forecast period of 2020-2027.

The regional analysis of global Needle Biopsy market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region due to the rise in number of reported cancer cases, high per capita health expenditure, and significant investment in R&D for effective treatment alternatives. Also, the dominance of the region is witnessed owing to the favorable reimbursement scenarios and greater expenditure on healthcare. Whereas Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Boston Scientific Corporation
Cook Medical
Carefusion Corporation
Hologic, Inc.
Cardinal Health, Inc.
C. R. Bard
Möller Medical Gmbh
Becton, Dickinson And Company
Hakko Co. Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. 

Share your love
Christophe Rude

Christophe Rude

Articles: 15888

Leave a Reply

Your email address will not be published. Required fields are marked *